Dermata Therapeutics, Inc. (DRMA)

Market Cap	3.86M +34.3%
Revenue (ttm)	n/a
Net Income	-8.37M
EPS	-3.33
Shares Out	4.02M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	138,971,978
Open	0.7685
Previous Close	0.6633
Day's Range	0.7658 - 1.1800
52-Week Range	0.6032 - 4.6600
Beta	0.66
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About DRMA

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Aug 13, 2021
• Employees: 9
• Stock Exchange: Nasdaq
• Ticker Symbol: DRMA
• Website: https://www.dermatarx.com

Financial Performance

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 15, 2026

Data Sources Report a data error